An Evaluation of the Safety and Performance of the CathVision Cube® System
2022年1月18日 更新者：CathVision ApS
The primary objective is to evaluate the safety and technical performance of the CathVision Cube® System.
The secondary objective is to benchmark the intracardiac electrogram signal quality compared to commercially available systems in patients undergoing assessment and ablation of cardiac arrhythmias.
研究概览
详细说明
A prospective, single center, open-label, single arm study to evaluate the safety and technical performance of the CathVision Cube® system.
Patients undergoing assessment and ablation of cardiac arrhythmias, by Electro Physiology (EP) procedure, and who meet all inclusion criteria will be enrolled in the study and undergo the EP procedure. Intracardiac signals will be passively recorded using the CathVision Cube® System in parallel with a commercial (CE marked) EP recording system and later compared and evaluated. The investigational device will not be used for direct clinical care decisions or therapy. The EP procedure will be guided by the study site Standards Of Care.
研究类型
介入性
注册 (实际的)
24
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Patient indicated by investigator for catheter ablation or diagnostic electrophysiology procedure.
- Male or non-pregnant female aged ≥18 years. Female patients of childbearing potential must have a negative pregnancy test (per site standard test) within 7 days prior to index procedure.
- Able and willing to directly provide informed consent.
Exclusion Criteria:
- Patient inability to understand or refusal to sign informed consent.
- Pregnant or nursing patients and those who plan pregnancy in the period up to 1 month following the index procedure.
- Current participation in another investigational drug or device study that interferes with this study.
- Patient is a prisoner.
- Patients who in the opinion of the physician are not candidates for this study. Prior atrial septal defect (ASD) or patent foramen ovale (PFO) closure with a device using a transcatheter percutaneous approach.
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：诊断
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
其他：A prospective, multi-center, open-label, single arm study
Patients undergoing assessment and ablation of cardiac arrhythmiast.
who are scheduled for an electrophysiology (EP) procedure and meet all inclusion criteria will be enrolled in the study and undergo the EP procedure.
Intracardiac signals will be passively recorded using the CathVision Cube® System in parallel with the commercial (CE marked) EP recording system for post procedure evaluation.
The investigational device will not be used for direct clinical care decisions or therapy.
The EP procedure will be guided by the study site Standards Of Care.
|
Intracardiac signals will be passively recorded using CathVision Cube® System in parallel with the commercial (CE marked) EP recording system during a scheduled electrophysiology procedure
其他名称：
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Freedom from major adverse events, evaluated at hospital discharge.
大体时间：From EP procedure to hospital discharge is 1 day
|
Freedom from major adverse events, evaluated at hospital discharge
|
From EP procedure to hospital discharge is 1 day
|
|
Recording low-voltage electrograms
大体时间：Duration of the EP procedure can take up to 6 hours
|
Recording low-voltage electrograms under 20uV amplitude
|
Duration of the EP procedure can take up to 6 hours
|
|
The Primary Performance endpoint of study will be evaluated as technical success of CathVision Cube® system to collect and record intracardiac signals during EP procedures
大体时间：Duration of the EP procedure can take up to 6 hours
|
Logging time for arrhythmia termination / block
|
Duration of the EP procedure can take up to 6 hours
|
|
Compatibility of Cube System with commercially available 3D mapping system
大体时间：Duration of the EP procedure can take up to 6 hours
|
Assessing compatibility of Cube System with commercially available 3D mapping system with available intracardiac catheters.
Compatibility is assessed by that the Cube System does not introduce a visual detectable distortion on the commercial available 3D mapping systems
|
Duration of the EP procedure can take up to 6 hours
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员：Josef Kautzner, Prof.、IKEM, Prague, Czech Republic
- 首席研究员：Peter K Jacobsen, MD, DMSc、Righospitalet, Copenhagen, Denmark
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2020年10月2日
初级完成 (实际的)
2021年7月9日
研究完成 (实际的)
2021年8月1日
研究注册日期
首次提交
2021年8月16日
首先提交符合 QC 标准的
2021年11月5日
首次发布 (实际的)
2021年11月10日
研究记录更新
最后更新发布 (实际的)
2022年2月1日
上次提交的符合 QC 标准的更新
2022年1月18日
最后验证
2021年11月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
心律失常的临床试验
EP Procedure的临床试验
-
eXIthera Pharmaceuticals撤销
-
National Institute of Allergy and Infectious Diseases...完全的
-
John SappNova Scotia Health Authority; Rochester Institute of Technology招聘中